Skip to main content

Irreversible Pulpitis clinical trials at UCSF
1 in progress, 0 open to eligible people

  • Residual Dental Pulp Tissue and Cord Blood Stem Cells

    Sorry, not yet accepting patients

    The experiments outlined in this proposal are designed to test the hypothesis that the in vivo injection of cord blood stem cells (InvitRx®) into the root canal system will facilitate teeth initially diagnosed with irreversible pulpitis, to form normal healthy pulpal tissue.

Last updated: